AstraZeneca, Pfizer Apply For Emergency Use Authorizations Of Coronavirus Vaccines In India
Wall Street Journal: AstraZeneca and Pfizer Ask India for Emergency-Use Covid-19 Vaccine Authorizations
“The companies behind two of the most promising Covid-19 vaccine candidates, AstraZeneca PLC and Pfizer Inc., have asked India for emergency-use authorization to start using their vaccines in the South Asian nation, which has been one of the worst hit by the pandemic. Both Pfizer and Serum Institute of India — which is manufacturing AstraZeneca’s vaccine for developing countries — have applied for the authorization, which would allow their vaccines to circumvent a long trial and application process, said an official at the Drugs Controller General of India…” (Bellman, 12/7).
Additional coverage of the applications is available from Axios and Reuters.
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.